Education
About Us
Working with TipRanks
Follow Us
CBD Denver Inc (CBDD)
OTHER OTC:CBDD
CBDD Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EST
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume395.10K
Average Volume (3M)N/A
Market Cap
$10.74K
Enterprise Value$1.95M
Total Cash (Recent Filing)$8.52K
Total Debt (Recent Filing)$979.65K
Price to Earnings (P/E)―
Beta-20.44
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding10,741,204,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.36
Price to Book (P/B)-2.18
Price to Sales (P/S)0.78
P/FCF Ratio-33.19
Enterprise Value/Market Cap181.74
Enterprise Value/Revenue0.81
Enterprise Value/Gross Profit9.81
Enterprise Value/Ebitda8.40
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Product DiversificationA diverse product range allows CBD Denver to cater to various consumer preferences, enhancing market reach and reducing dependency on a single product line.
Strategic PartnershipsStrategic partnerships help CBD Denver achieve cost efficiencies and maintain high product quality, which can lead to improved margins and competitive advantage.
Revenue ChannelsMultiple revenue channels provide CBD Denver with a stable income stream, reducing risk associated with reliance on a single sales avenue and supporting long-term growth.
Bears Say
High Debt LevelsHigh leverage and negative equity indicate financial risk, potentially limiting CBD Denver's ability to invest in growth opportunities and affecting long-term stability.
Negative Cash FlowNegative operating cash flow suggests cash management issues, which could hinder CBD Denver's ability to fund operations and invest in future growth without external financing.
Volatile Revenue TrendsVolatile revenue trends indicate instability in market demand or operational execution, which could challenge CBD Denver's ability to achieve consistent growth.
CBDD FAQ
What was CBD Denver Inc’s price range in the past 12 months?
Currently, no data Available
What is CBD Denver Inc’s market cap?
CBD Denver Inc’s market cap is $10.74K.
When is CBD Denver Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were CBD Denver Inc’s earnings last quarter?
Currently, no data Available
Is CBD Denver Inc overvalued?
According to Wall Street analysts CBD Denver Inc’s price is currently Overvalued.
Does CBD Denver Inc pay dividends?
CBD Denver Inc does not currently pay dividends.
What is CBD Denver Inc’s EPS estimate?
CBD Denver Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CBD Denver Inc have?
CBD Denver Inc has 10,741,204,000 shares outstanding.
What happened to CBD Denver Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of CBD Denver Inc?
Currently, no hedge funds are holding shares in CBDD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
CBD Denver Inc
CBD of Denver Inc. engages in developing and commercializing cannabidiol (CBD) products. It is involved in the research, development, and distribution of premium hemp extract products. The company was formerly known as Verde Media Group, Inc. and changed its name to CBD of Denver Inc. in 2018. CBD of Denver Inc. is based in Centennial, Colorado. CBD of Denver Inc. operates as a subsidiary of Swiss Industry Ventures AG.
cbdMD
―
Dermata Therapeutics
―
Bluejay Diagnostics
―
Tivic Health Systems
―
CERo Therapeutics Holdings
―
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---